[1]
Zahoor, W. et al. 2023. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA. Experimental Oncology. 45, 2 (Oct. 2023), 203–210. DOI:https://doi.org/10.15407/exp-oncology.2023.02.203.